For the first time, a drug has been shown to meaningfully extend life in people with the most deadly and common form of brain cancer.

This is the biggest advance in treating the disease in 30 years and it was announced during a meeting of 25,000 cancer experts in New Orleans.

Patients given low, daily doses of temozolomide along with radiation treatment were more than twice as likely to be alive two years later as those who got radiation alone, a new study presented to the American Clinical Society found.

The study involved nearly 600 patients at 85 hospitals throughout Europe, Canada and Australia. Half got daily pills of temozolomide during radiation treatment and for six months afterward. The others got radiation alone.

After two years, 26 percent who got the drugs were alive, vs. 10 percent who got just radiation, said Roger Stupp, a doctor at University Hospital in Lausanne, Switzerland, who led the study.

Meanwhile, German magazine Focus reported that a supra-mini computer composed of DNA-molecules had been designed for in-body search of cancer-hit cells. The two Israeli designers have planned it as a pill, which - if needed - would also sparkle the medicine.

We need your support so Novinite.com can keep delivering news and information about Bulgaria! Thank you!